Evidence map›Paper›PMID 41738831›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

Uncomplicated Urinary Tract Infections: From an Invisible Impact to a Visible Change in Complex Care.

Rafael Cantón, Ai-Nee Lim, Vanessa Cortés, Jazmín Díaz-Regañón

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rafael CantónServicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Ai-Nee LimDepartment of Microbiology, Whittington Health NHS Trust, London, United Kingdom.ORCID 0009-0003-9211-3036
Vanessa CortésGSK, Bogota, Colombia.
Jazmín Díaz-RegañónGSK, Madrid, Spain.ORCID 0009-0004-8723-691X

Funding

European Society of Clinical Microbiology and Infectious DiseasesGSK
6 · The paper itself

Abstract

Uncomplicated urinary tract infections can cause significant physical and emotional burden for patients, with high rates of recurrence. The challenges of treating uncomplicated urinary tract infections are exacerbated by rising antimicrobial resistance in key uropathogens, primarily Escherichia coli, on a global scale. Clinicians should consider drug, pathogen, and host-related factors when selecting the most appropriate therapy.

Indexed as

Anti-Bacterial AgentsUrinary Tract InfectionsDrug Resistance, BacterialEscherichia coliEscherichia coli InfectionsHumansAnti-Bacterial Agentsantibioticsantimicrobial resistanceepidemiologytreatment guidelinesuncomplicated UTI

Identifiers

PMID41738831
PMCPMC13341222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.